Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
Newall, AT;
Jit, M;
Hutubessy, R;
(2014)
Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
PharmacoEconomics, 32 (12).
1247-.
ISSN 1170-7690
DOI: https://doi.org/10.1007/s40273-014-0232-0
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.